CHICAGO, Jan. 6, 2010 (GLOBE NEWSWIRE) -- WHI Capital Partners is pleased to announce the appointment of Nicki Norris as Chief Executive Officer of its portfolio company, Clinical Resource Network (www.clinicalresource.net), a leading provider of specialized in-home and alternate-site healthcare services to patients in all phases and therapeutic areas of clinical trials. CRN's services significantly accelerate the pace of clinical trials by leveraging its growing network of home healthcare agencies to increase convenience for patients. CRN helps clinical trial sponsors dramatically improve patient recruitment, compliance and retention as well as increase patient and investigator satisfaction.
Nicki Norris brings more than 30 years of experience as a healthcare executive, having successfully led three diverse healthcare services organizations. As the new CEO of CRN, she will be leading a global management team that combines backgrounds from such premier industry sponsors as Abbott Laboratories, Baxter Healthcare Corporation, GlaxoSmithKline, Takeda, Astellas (Fujisawa), Caremark, and other homecare, pharmacy and clinical service providers.
"We are extremely excited about Nicki joining the organization and leading CRN as it continues to expand its relationship with the some of the largest and most active healthcare companies in the world," said Adam Schecter, Managing Partner of WHI Capital Partners. "Her deep experience and unwavering commitment to quality and customer service will be invaluable as CRN enhances its services to serve the diverse and expanding needs of clinical research programs."
About Clinical Resource Network, LLC
Clinical Resource Network (www.clinicalresource.net) is a provider to biotechnology, pharmaceutical and other healthcare companies of specialized in-home and alternate site clinical services utilized primarily to expedite clinical trial studies across all phases and therapeutic areas. CRN partners with its customers and their contract research organizations to enhance patient recruitment, data collection and patient retention within the clinical trial process.
About WHI Capital Partners
WHI Capital Partners (www.whicapital.com) is a Chicago based private equity firm established to invest in mid-size companies that have been consistently profitable. Whether for a long term partnership or for a complete sale of their business, business owners choose us as a partner because we bring more than capital to the transaction. Our strong and enduring values, deep operational expertise, committed capital, and long term investment perspective make us a preferred partner for business owners seeking to take their business to the next level, locate an ethical capital partner, or sell the company- leaving their legacy in good hands. Our investment philosophy is based upon a 60-year heritage of successfully growing middle market companies into larger, more profitable organizations.
The WHI Capital Partners logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4787